What is the future of biopharmaceuticals in chronic disease management?

A clinical-stage biopharmaceutical company focused on rare diseases, today provided an update on its lead clinical programs, setrusumab. The following Q&A is intended to help answer questions about the delisting of the PDL BioPharma, Inc.'s (PDL or the Company) stock and Plan of Dissolution. Our team has deep expertise in the discovery, development, and regulatory approval of anti-infective medicines, including an extensive record of working with ... The Genedata Biopharma Platform is first-in-class enterprise software that automates and digitalizes research, discovery, and manufacturing to drive scientific ... As the icon of next-generation CDMOs, KBI Biopharma is driving breakthroughs in biopharmaceutical development and manufacturing that positively impact the ... Scientific excellence driven by the need for innovative solutions for patients. Our Passion for Innovation Journal overview ... Statistics in Biopharmaceutical Research accepts papers that discuss appropriate statistical methodology and information regarding the use of ... TransCelerate BioPharma is a non-profit catalyst for change in clinical research. We unite diverse voices across biopharmaceutical R&D to drive innovation, ... Oct 27, 2022 ... The Helix report argues that if companies are to make another leap forward, they may need to recalibrate their formula for success. Biohaven is a biopharmaceutical company focused on the discovery, development and commercialization of life-changing treatments in key therapeutic areas ...